Analog teraflex - the drug "Arthra"

The Russian pharmacy market has recently been replenished with a novelty - an imported drug - the chondroprotector "Artra" (manufactured by the American company Unifarm). Judging by the composition, the arthra tablets can be used as a substitute for teraflex (a preparation produced in the UK). Both drugs are stimulators of cartilage regeneration and belong to the same price category. The only difference is that in artra and teraflex the active components in the form of chondroitin sulfate and glucosamine hydrochloride are contained in different ratios.

Arthra prevents the development of degenerative-dystrophic processes in the cartilage. In addition, this teraflex analog is effective in the treatment of osteoarthrosis, and in particular, osteochondrosis of the spine. By the way, the modified medicinal product - artra chondroitin is also produced. It includes only one ingredient - chondroitin sulfate. Acting just like teraflex, the capsules of this drug protect joints from pathogenic action, restore cartilaginous tissue, improving the metabolism inside it. Justified the appointment of arthritis with non-steroidal anti-inflammatory drugs. Vitamins of group B and antispasmodics are also combined with it.

Indications for arthritis can be both acute and chronic periods of the disease. But in the acute stage before taking this analog teraflex, it is not superfluous to undergo a course of injection forms of chondroprotectors (for example, chondrolone).

As for the therapeutic effect of arthritis, it appears gradually due to prolonged exposure. During the first three weeks, the medicine is taken 1 capsule or tablet two to three times a day. The frequency of reception depends on the dosage of the drug, available in three types: 250, 500 and 750 mg. Next, they switch to a two-time intake for three to four months (a dose less than two tablets or capsules a day usually does not have a significant therapeutic effect). In breaks between courses it is recommended to use gels, creams and ointments containing chondroitin. Only then will a full-fledged therapeutic effect be achieved. And it should be remembered that the use of the drug in one course is absolutely pointless.

Arthra reduces the pain syndrome and suppresses the inflammatory process in the joints, normalizing their mobility. Another advantage of the drug treatment is a decrease in calcium loss by the body. No side effects were observed when taking the medication. This analogue of teraflex is contraindicated only with individual intolerance.

Considering the mechanism of the effect of arthritis, it should be noted that this chondroprotector contributes not so much to eliminating the symptoms of arthrosis as to the effect on the "basis" of the disease: it restores the cartilaginous surface of the diseased joint, improves the production of the joint fluid and normalizes its "lubricating" properties.

This complex effect of this drug on the joints makes it indispensable in the therapy of the initial stage of arthrosis. If we evaluate the therapeutic effect of arthritis in comparison with other chondroprotectors, then this remedy can be considered the most balanced. In addition, it is tested by repeated clinical trials.

However, do not exaggerate the possibility of arthras. Like any chondroprotector, this teraflex analog is ineffective in the last stage of arthrosis, that is, when the cartilage is completely destroyed. After all, the growth of a new cartilaginous tissue or the return of the old form to deformed bones, jointed in the joint with the help of chondroprotectors, is not possible.

Thus, arthra is not an all-powerful remedy. Treatment with this medicine requires its long reception and it is better if the therapy is combined with other methods.